Ketoacidosis in type 2 diabetics on SGLT-2 inhibitors
Completed
- Conditions
- Type 2 diabetes mellitusNutritional, Metabolic, Endocrine
- Registration Number
- ISRCTN96827601
- Lead Sponsor
- Southend University Hospital NHS Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1. Patients with type 2 diabetes taking SGLT2i
2. Age > 18
3. Able to give consent
Exclusion Criteria
Participants that do not meet inclusion criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of episodes of ketoacidosis, from blood analyses using samples taken via a pin prick test or blood test. Measured at baseline and when the participant is feeling unwell during the study period.
- Secondary Outcome Measures
Name Time Method